Magnetic Separation of HbS Red Blood Cells to Prevent Iron Overload
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and managing sickle cell disease lack a rapid and reliable point-of-care test, leading to challenges in detecting acute crises, managing pain, and addressing health disparities, particularly in resource-limited settings.
Innovation Solution
A method utilizing changes in magnetic properties of red blood cells to diagnose and quantify the severity of hemoglobinopathies, including sickle cell disease, through cell tracking velocimetry (CTV) and blood oxygen binding system (BOBS) analysis, enabling the identification of pathological cells and guiding treatment decisions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If red blood cell transfusions are administered to treat sickle cell disease, then the concentration of HbS-containing RBCs is diluted and complications of vaso-occlusive crises are prevented, but iron overload occurs causing significant morbidity and mortality
Solution Approach 1:
The patent extracts and removes HbS-containing red blood cells from the patient's circulation using magnetic separation technology. By applying magnetic fields to selectively bind and remove pathological cells, the treatment achieves dilution of HbS concentration without the harmful iron overload associated with conventional transfusions that add more RBCs to the system.
Solution Approach 2:
The patent introduces magnetic particles as an intermediary substance that binds to HbS-containing RBCs, enabling selective identification and removal. These magnetic intermediaries allow the system to target and extract pathological cells without requiring direct chemical interaction with the patient's blood components, thus avoiding iron overload while achieving therapeutic dilution.
2Reliability
If erythrocytapheresis (RBC exchange transfusion) is performed to selectively remove HbS-containing RBCs, then the concentration of pathological cells is reduced, but expensive and complex machinery is required that is only available at large academic hospitals
Solution Approach 1:
The patent replaces the complex mechanical centrifugation system of erythrocytapheresis with a simpler magnetic field-based separation system. Instead of using expensive centrifugal machines that require sophisticated mechanical components, the invention uses magnetic particles and magnetic fields to achieve selective cell removal, dramatically simplifying the device while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent changes the separation mechanism from mechanical centrifugal force to magnetic field interaction. By altering the physical parameter used for cell separation (from mechanical force to magnetic susceptibility), the system achieves selective removal of HbS-containing RBCs using simple, inexpensive magnetic materials rather than complex erythrocytapheresis machinery.
3Quantity of substance
If simple RBC transfusion is performed to dilute HbS concentration, then the patient's total blood volume increases, but the concentration of HbS-containing RBCs is only partially reduced
Solution Approach 1:
The patent actively extracts HbS-containing RBCs from the patient's blood using magnetic separation, rather than passively diluting them through transfusion. This extraction approach directly removes pathological cells, achieving more efficient reduction of HbS concentration without merely adding volume to dilute the pathogen.
Solution Approach 2:
The patent uses magnetic particles as intermediaries to selectively bind and remove HbS-containing RBCs. This intermediary mechanism enables precise targeting and extraction of pathological cells, achieving superior efficiency in reducing HbS concentration compared to simple dilution through transfusion.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a rapid, affordable, and effective means to diagnose sickle cell disease and other hemoglobinopathies, facilitating timely treatment and reducing health disparities by enabling the identification of at-risk populations and intensifying disease modification.
Implementation Method 1
diagnosing and managing sickle cell disease lack a rapid and reliable point-of-care test... utilizing changes in magnetic properties of red blood cells to diagnose and quantify the severity of hemoglobinopathies
Data Source
AI summary
The present disclosure provides methods to diagnose and/or treat hemoglobinopathies via comparative analysis of cell magnetic properties.